 | • レポートコード：D005-11483 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、眼科用薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。眼科用薬品の種類別市場規模（網膜障害治療薬、アレルギー・炎症・感染症治療薬、緑内障治療薬、ドライアイ治療薬）、用途別市場規模（緑内障、ドライアイ症候群、網膜疾患、その他眼科適応症）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Pfizer、Valeant、Allergan、Bayer、Roche、Akorn、Santen、Regeneron、Senju ・地域別グローバル市場分析 2015年-2020年 ・眼科用薬品の北米市場（アメリカ、カナダ、メキシコ） ・眼科用薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・眼科用薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・眼科用薬品の南米市場（ブラジル、アルゼンチン） ・眼科用薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：網膜障害治療薬、アレルギー・炎症・感染症治療薬、緑内障治療薬、ドライアイ治療薬 ・用途別分析：緑内障、ドライアイ症候群、網膜疾患、その他眼科適応症 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Ophthalmol Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Ophthalmol Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Ophthalmol Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Ophthalmol Drug market has been segmented into
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
By Application, Ophthalmol Drug has been segmented into:
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Ophthalmol Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Ophthalmol Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Ophthalmol Drug market.
The report offers in-depth assessment of the growth and other aspects of the Ophthalmol Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Ophthalmol Drug Market Share Analysis
Ophthalmol Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Ophthalmol Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Ophthalmol Drug sales, revenue and market share for each player covered in this report.
The major players covered in Ophthalmol Drug are:
Novartis
Pfizer
Valeant
Allergan
Bayer
Roche
Akorn
Santen
Regeneron
Senju
Among other players domestic and global, Ophthalmol Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Ophthalmol Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Ophthalmol Drug, with price, sales, revenue and global market share of Ophthalmol Drug in 2018 and 2019.
Chapter 3, the Ophthalmol Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Ophthalmol Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Ophthalmol Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Ophthalmol Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Ophthalmol Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Ophthalmol Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Retinal disorders drugs
1.2.3 Allergic, inflammatory and infective drugs
1.2.4 Glaucoma drugs
1.2.5 Dry eye drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Ophthalmol Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Glaucoma
1.3.3 Dry eye syndrome
1.3.4 Retinal diseases
1.3.5 Other ophthalmic indications
1.4 Overview of Global Ophthalmol Drug Market
1.4.1 Global Ophthalmol Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Valeant
2.3.1 Valeant Details
2.3.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Valeant SWOT Analysis
2.3.4 Valeant Product and Services
2.3.5 Valeant Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Allergan
2.4.1 Allergan Details
2.4.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Allergan SWOT Analysis
2.4.4 Allergan Product and Services
2.4.5 Allergan Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bayer SWOT Analysis
2.5.4 Bayer Product and Services
2.5.5 Bayer Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Roche
2.6.1 Roche Details
2.6.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Roche SWOT Analysis
2.6.4 Roche Product and Services
2.6.5 Roche Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Akorn
2.7.1 Akorn Details
2.7.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Akorn SWOT Analysis
2.7.4 Akorn Product and Services
2.7.5 Akorn Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Santen
2.8.1 Santen Details
2.8.2 Santen Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Santen SWOT Analysis
2.8.4 Santen Product and Services
2.8.5 Santen Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Regeneron
2.9.1 Regeneron Details
2.9.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Regeneron SWOT Analysis
2.9.4 Regeneron Product and Services
2.9.5 Regeneron Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Senju
2.10.1 Senju Details
2.10.2 Senju Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Senju SWOT Analysis
2.10.4 Senju Product and Services
2.10.5 Senju Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Ophthalmol Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Ophthalmol Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Ophthalmol Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Ophthalmol Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Ophthalmol Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Ophthalmol Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Ophthalmol Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Ophthalmol Drug Sales and Growth Rate (2015-2020)
4.3 Europe Ophthalmol Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Ophthalmol Drug Sales and Growth Rate (2015-2020)
4.5 South America Ophthalmol Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Ophthalmol Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Ophthalmol Drug Sales, Revenue and Market Share by Country
5.1.1 North America Ophthalmol Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Ophthalmol Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Ophthalmol Drug Sales and Growth Rate (2015-2020)
5.3 Canada Ophthalmol Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Ophthalmol Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Ophthalmol Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Ophthalmol Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Ophthalmol Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Ophthalmol Drug Sales and Growth Rate (2015-2020)
6.3 UK Ophthalmol Drug Sales and Growth Rate (2015-2020)
6.4 France Ophthalmol Drug Sales and Growth Rate (2015-2020)
6.5 Russia Ophthalmol Drug Sales and Growth Rate (2015-2020)
6.6 Italy Ophthalmol Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Ophthalmol Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Ophthalmol Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Ophthalmol Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Ophthalmol Drug Sales and Growth Rate (2015-2020)
7.3 Japan Ophthalmol Drug Sales and Growth Rate (2015-2020)
7.4 Korea Ophthalmol Drug Sales and Growth Rate (2015-2020)
7.5 India Ophthalmol Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Ophthalmol Drug Sales and Growth Rate (2015-2020)
7.7 Australia Ophthalmol Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Ophthalmol Drug Sales, Revenue and Market Share by Country
8.1.1 South America Ophthalmol Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Ophthalmol Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Ophthalmol Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Ophthalmol Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Ophthalmol Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Ophthalmol Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Ophthalmol Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Ophthalmol Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Ophthalmol Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Ophthalmol Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Ophthalmol Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Ophthalmol Drug Sales and Market Share by Type (2015-2020)
10.2 Global Ophthalmol Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Ophthalmol Drug Price by Type (2015-2020)
11 Global Ophthalmol Drug Market Segment by Application
11.1 Global Ophthalmol Drug Sales Market Share by Application (2015-2020)
11.2 Global Ophthalmol Drug Revenue Market Share by Application (2015-2020)
11.3 Global Ophthalmol Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Ophthalmol Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Ophthalmol Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Ophthalmol Drug Market Forecast (2021-2025)
12.2.2 Europe Ophthalmol Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Ophthalmol Drug Market Forecast (2021-2025)
12.2.4 South America Ophthalmol Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Ophthalmol Drug Market Forecast (2021-2025)
12.3 Ophthalmol Drug Market Forecast by Type (2021-2025)
12.3.1 Global Ophthalmol Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Ophthalmol Drug Market Share Forecast by Type (2021-2025)
12.4 Ophthalmol Drug Market Forecast by Application (2021-2025)
12.4.1 Global Ophthalmol Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Ophthalmol Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Ophthalmol Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Ophthalmol Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Ophthalmol Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Ophthalmol Drug Major Business
Table 9. Novartis Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 10. Novartis SWOT Analysis
Table 11. Novartis Ophthalmol Drug Product and Services
Table 12. Novartis Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Ophthalmol Drug Major Business
Table 15. Pfizer Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 16. Pfizer SWOT Analysis
Table 17. Pfizer Ophthalmol Drug Product and Services
Table 18. Pfizer Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Valeant Basic Information, Manufacturing Base and Competitors
Table 20. Valeant Ophthalmol Drug Major Business
Table 21. Valeant Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 22. Valeant SWOT Analysis
Table 23. Valeant Ophthalmol Drug Product and Services
Table 24. Valeant Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Allergan Basic Information, Manufacturing Base and Competitors
Table 26. Allergan Ophthalmol Drug Major Business
Table 27. Allergan Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 28. Allergan SWOT Analysis
Table 29. Allergan Ophthalmol Drug Product and Services
Table 30. Allergan Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Bayer Basic Information, Manufacturing Base and Competitors
Table 32. Bayer Ophthalmol Drug Major Business
Table 33. Bayer Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 34. Bayer SWOT Analysis
Table 35. Bayer Ophthalmol Drug Product and Services
Table 36. Bayer Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Roche Basic Information, Manufacturing Base and Competitors
Table 38. Roche Ophthalmol Drug Major Business
Table 39. Roche Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 40. Roche SWOT Analysis
Table 41. Roche Ophthalmol Drug Product and Services
Table 42. Roche Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Akorn Basic Information, Manufacturing Base and Competitors
Table 44. Akorn Ophthalmol Drug Major Business
Table 45. Akorn Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 46. Akorn SWOT Analysis
Table 47. Akorn Ophthalmol Drug Product and Services
Table 48. Akorn Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Santen Basic Information, Manufacturing Base and Competitors
Table 50. Santen Ophthalmol Drug Major Business
Table 51. Santen Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 52. Santen SWOT Analysis
Table 53. Santen Ophthalmol Drug Product and Services
Table 54. Santen Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Regeneron Basic Information, Manufacturing Base and Competitors
Table 56. Regeneron Ophthalmol Drug Major Business
Table 57. Regeneron Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 58. Regeneron SWOT Analysis
Table 59. Regeneron Ophthalmol Drug Product and Services
Table 60. Regeneron Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Senju Basic Information, Manufacturing Base and Competitors
Table 62. Senju Ophthalmol Drug Major Business
Table 63. Senju Ophthalmol Drug Total Revenue (USD Million) (2018-2019)
Table 64. Senju SWOT Analysis
Table 65. Senju Ophthalmol Drug Product and Services
Table 66. Senju Ophthalmol Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Ophthalmol Drug Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Ophthalmol Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Ophthalmol Drug Sales by Regions (2015-2020) (K MT)
Table 70. Global Ophthalmol Drug Sales Market Share by Regions (2015-2020)
Table 71. Global Ophthalmol Drug Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Ophthalmol Drug Sales by Countries (2015-2020) (K MT)
Table 73. North America Ophthalmol Drug Sales Market Share by Countries (2015-2020)
Table 74. North America Ophthalmol Drug Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Ophthalmol Drug Revenue Market Share by Countries (2015-2020)
Table 76. Europe Ophthalmol Drug Sales by Countries (2015-2020) (K MT)
Table 77. Europe Ophthalmol Drug Sales Market Share by Countries (2015-2020)
Table 78. Europe Ophthalmol Drug Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Ophthalmol Drug Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Ophthalmol Drug Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Ophthalmol Drug Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Ophthalmol Drug Sales by Countries (2015-2020) (K MT)
Table 83. South America Ophthalmol Drug Sales Market Share by Countries (2015-2020)
Table 84. South America Ophthalmol Drug Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Ophthalmol Drug Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Ophthalmol Drug Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Ophthalmol Drug Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Ophthalmol Drug Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Ophthalmol Drug Revenue Market Share by Countries (2015-2020)
Table 90. Global Ophthalmol Drug Sales by Type (2015-2020) (K MT)
Table 91. Global Ophthalmol Drug Sales Share by Type (2015-2020)
Table 92. Global Ophthalmol Drug Revenue by Type (2015-2020) (USD Million)
Table 93. Global Ophthalmol Drug Revenue Share by Type (2015-2020)
Table 94. Global Ophthalmol Drug Sales by Application (2015-2020) (K MT)
Table 95. Global Ophthalmol Drug Sales Share by Application (2015-2020)
Table 96. Global Ophthalmol Drug Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Ophthalmol Drug Market Share Forecast by Regions (2021-2025)
Table 98. Global Ophthalmol Drug Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Ophthalmol Drug Market Share Forecast by Type (2021-2025)
Table 100. Global Ophthalmol Drug Sales Forecast by Application (2021-2025)
Table 101. Global Ophthalmol Drug Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Ophthalmol Drug Picture
Figure 2. Global Sales Market Share of Ophthalmol Drug by Type in 2019
Figure 3. Retinal disorders drugs Picture
Figure 4. Allergic, inflammatory and infective drugs Picture
Figure 5. Glaucoma drugs Picture
Figure 6. Dry eye drugs Picture
Figure 7. Ophthalmol Drug Sales Market Share by Application in 2018
Figure 8. Glaucoma Picture
Figure 9. Dry eye syndrome Picture
Figure 10. Retinal diseases Picture
Figure 11. Other ophthalmic indications Picture
Figure 12. Global Ophthalmol Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Ophthalmol Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Ophthalmol Drug Sales Market Share by Manufacturer in 2019
Figure 33. Global Ophthalmol Drug Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Ophthalmol Drug Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Ophthalmol Drug Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 38. Global Ophthalmol Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Ophthalmol Drug Revenue Market Share by Regions (2015-2020)
Figure 40. Global Ophthalmol Drug Revenue Market Share by Regions in 2018
Figure 41. North America Ophthalmol Drug Sales and Growth Rate (2015-2020)
Figure 42. Europe Ophthalmol Drug Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Ophthalmol Drug Sales and Growth Rate (2015-2020)
Figure 44. South America Ophthalmol Drug Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Ophthalmol Drug Sales and Growth Rate (2015-2020)
Figure 46. North America Ophthalmol Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Ophthalmol Drug Sales Market Share by Countries (2015-2020)
Figure 48. North America Ophthalmol Drug Sales Market Share by Countries in 2018
Figure 49. North America Ophthalmol Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Ophthalmol Drug Revenue Market Share by Countries in 2018
Figure 51. United States Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Canada Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Mexico Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Europe Ophthalmol Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Ophthalmol Drug Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Ophthalmol Drug Revenue Market Share by Countries in 2019
Figure 57. Germany Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 58. UK Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 59. France Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Russia Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Italy Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Asia-Pacific Ophthalmol Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Ophthalmol Drug Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Ophthalmol Drug Revenue Market Share by Regions 2019
Figure 65. China Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Japan Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Korea Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 68. India Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 69. Southeast Asia Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 70. South America Ophthalmol Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Ophthalmol Drug Sales Market Share by Countries in 2019
Figure 72. South America Ophthalmol Drug Revenue Market Share by Countries in 2019
Figure 73. Brazil Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Argentina Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Middle East and Africa Ophthalmol Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Ophthalmol Drug Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Ophthalmol Drug Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Ophthalmol Drug Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Egypt Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Turkey Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 82. South Africa Ophthalmol Drug Sales and Growth Rate (2015-2020) (K MT)
Figure 83. Global Ophthalmol Drug Sales and Growth Rate (2021-2025) (K MT)
Figure 84. Global Ophthalmol Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Ophthalmol Drug Market Forecast (2021-2025) (K MT)
Figure 86. Europe Sales Ophthalmol Drug Market Forecast (2021-2025) (K MT)
Figure 87. Asia-Pacific Sales Ophthalmol Drug Market Forecast (2021-2025) (K MT)
Figure 88. South America Sales Ophthalmol Drug Market Forecast (2021-2025) (K MT)
Figure 89. Middle East & Africa Sales Ophthalmol Drug Market Forecast (2021-2025) (K MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
網膜薬及び生物製剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Retinal Drugs and Biologics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinal Drugs and…- バーター症候群薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Bartter Syndrome Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bartter Syndrome Drugs…
- 骨髄異形成症候群（MDS）薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Myelodysplastic Syndrome (MDS) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 1798.3 million by 2025, from USD 1452.7 million in 2019. The…
- 骨髄増殖性疾患薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Myeloproliferative Disorders Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.8% in the forecast period of 2020 to 2025 and will expected to reach USD 7146 million by 2025, from USD 6642.1 million in 2019. The Mye…
- 下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 20…